Sanofi Non Currrent Assets Other from 2010 to 2024
| SNY Stock | USD 47.98 0.20 0.42% |
Non Currrent Assets Other | First Reported 2002-06-30 | Previous Quarter -8.7 B | Current Value 16.4 B | Quarterly Volatility 7.7 B |
Check Sanofi ADR financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Sanofi ADR's main balance sheet or income statement drivers, such as Depreciation And Amortization of 3.3 B, Interest Expense of 607 M or Selling General Administrative of 11.2 B, as well as many indicators such as Price To Sales Ratio of 1.17, Dividend Yield of 0.0823 or PTB Ratio of 0.73. Sanofi financial statements analysis is a perfect complement when working with Sanofi ADR Valuation or Volatility modules.
Sanofi | Non Currrent Assets Other |
Latest Sanofi ADR's Non Currrent Assets Other Growth Pattern
Below is the plot of the Non Currrent Assets Other of Sanofi ADR over the last few years. It is assets that are not physical or tangible, expected to provide value for more than one year, and not easily converted into cash, such as long-term investments or patents. Sanofi ADR's Non Currrent Assets Other historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Sanofi ADR's overall financial position and show how it may be relating to other accounts over time.
| Non Currrent Assets Other | 10 Years Trend |
|
Non Currrent Assets Other |
| Timeline |
Sanofi Non Currrent Assets Other Regression Statistics
| Arithmetic Mean | 2,602,110,000 | |
| Geometric Mean | 1,306,330,755 | |
| Coefficient Of Variation | 168.39 | |
| Mean Deviation | 2,873,924,000 | |
| Median | 989,000,000 | |
| Standard Deviation | 4,381,633,038 | |
| Sample Variance | 19198708.1T | |
| Range | 13.3B | |
| R-Value | 0.61 | |
| Mean Square Error | 12942205.9T | |
| R-Squared | 0.37 | |
| Significance | 0.02 | |
| Slope | 599,205,536 | |
| Total Sum of Squares | 268781913.1T |
Sanofi Non Currrent Assets Other History
About Sanofi ADR Financial Statements
Sanofi ADR investors use historical fundamental indicators, such as Sanofi ADR's Non Currrent Assets Other, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Sanofi ADR. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Non Currrent Assets Other | 13.1 B | 13.7 B |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Sanofi Stock Analysis
When running Sanofi ADR's price analysis, check to measure Sanofi ADR's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sanofi ADR is operating at the current time. Most of Sanofi ADR's value examination focuses on studying past and present price action to predict the probability of Sanofi ADR's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sanofi ADR's price. Additionally, you may evaluate how the addition of Sanofi ADR to your portfolios can decrease your overall portfolio volatility.